Cargando…

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA

Detalles Bibliográficos
Autores principales:	Järver, Peter, Coursindel, Thibault, Andaloussi, Samir EL, Godfrey, Caroline, Wood, Matthew JA, Gait, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390225/ https://www.ncbi.nlm.nih.gov/pubmed/23344079 http://dx.doi.org/10.1038/mtna.2012.18

Ejemplares similares

Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides
por: Järver, Peter, et al.
Publicado: (2015)

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
por: Juliano, Rudy, et al.
Publicado: (2008)

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
por: Betts, Corinne, et al.
Publicado: (2012)

Delivery of therapeutic oligonucleotides with cell penetrating peptides()
por: Boisguérin, Prisca, et al.
Publicado: (2015)

Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides
por: Juliano, Rudolph L
Publicado: (2020)

PFRED: A computational platform for siRNA and antisense oligonucleotides design
por: Sciabola, Simone, et al.
Publicado: (2021)

Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo
por: Griesenbach, Uta, et al.
Publicado: (2006)

Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy
por: Roberts, Thomas C, et al.
Publicado: (2012)

Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy
por: Shabanpoor, Fazel, et al.
Publicado: (2015)

Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo
por: Bazaz, Safa, et al.
Publicado: (2021)

RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
por: Lima, Walt F., et al.
Publicado: (2016)

Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
por: Roberts, Thomas C., et al.
Publicado: (2015)

Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides
por: Bost, Jeremy P., et al.
Publicado: (2022)

Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
por: Betigeri, Seema, et al.
Publicado: (2010)

Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
por: Shabanpoor, Fazel, et al.
Publicado: (2017)

Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
por: Wang, Mingxing, et al.
Publicado: (2020)

Amphiphilic Peptides for Efficient siRNA Delivery
por: Mozaffari, Saghar, et al.
Publicado: (2019)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
por: Daralnakhla, Haneen, et al.
Publicado: (2021)

Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions
por: Ezzat, Kariem, et al.
Publicado: (2012)

PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation
por: Ezzat, Kariem, et al.
Publicado: (2011)

Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice
por: Cooper, J Mark, et al.
Publicado: (2014)

Natural Antisense Makes Sense for Gene-specific Activation in Brain
por: Varela, Miguel A, et al.
Publicado: (2012)

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
por: EL Andaloussi, Samir, et al.
Publicado: (2011)

Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment
por: Gait, Michael J., et al.
Publicado: (2019)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo
por: Yang, Liu, et al.
Publicado: (2020)

Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation
por: Gupta, Dhanu, et al.
Publicado: (2023)

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides
por: Hammond, Suzan M, et al.
Publicado: (2014)

Difatty Acyl-Conjugated Linear and Cyclic Peptides for siRNA Delivery
por: Do, Hung, et al.
Publicado: (2017)

Targeted delivery of antisense oligonucleotides to pancreatic β-cells
por: Ämmälä, C., et al.
Publicado: (2018)

Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
por: Ren, Yin, et al.
Publicado: (2012)

Versatility of cell-penetrating peptides for intracellular delivery of siRNA
por: Singh, Tejinder, et al.
Publicado: (2018)

Hydrocarbon-Stapled Peptide Based-Nanoparticles for siRNA Delivery
por: Simon, Matthieu, et al.
Publicado: (2020)

Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Nasrolahi Shirazi, Amir, et al.
Publicado: (2021)

Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
por: Ke, Junfeng, et al.
Publicado: (2022)

In vivo and in vitro studies of antisense oligonucleotides – a review
por: Kilanowska, Anna, et al.
Publicado: (2020)

Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide
por: Yang, Shuang, et al.
Publicado: (2019)

Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design
por: Lu, Zhi John, et al.
Publicado: (2008)

In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice
por: Eadon, Michael T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b3o05bhovdrh0pu2md84o34u6b